Formedix are pleased to announce a new partnership with CAC Croit and Innovion to provide CDISC services and support for global drug submissions to regulatory authorities. Formedix and Innovion's extensive experience using CDISC to accelerate trials in the US and Europe for FDA and EMA submissions combined with CAC Croit's knowledge of PMDA submissions in Japan will bring the benefits of CDISC standards to the Japanese market.
See the press release.